US17 is a clinical research site located in Tucson, Arizona, United States 85711.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
US17 has participated in 1 clinical trials.
Therapeutic areas: Multiple Myeloma.
Sponsors: Oncopeptides AB.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
US17 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
US17 has 1 clinical trials on record. Their work covers Multiple Myeloma.
US17 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.